Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert W Leong

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
The Lancet. Gastroenterology & Hepatology|December 5, 2021
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trialCraig Haifer, Sudarshan Paramsothy, Nadeem O Kaakoush, et al.
Therapeutic Advances in Gastroenterology|November 3, 2025
Microbiota-targeted strategies in IBD: therapeutic promise of 2'-fucosyllactose and beyondNicholas Fanous, Nicholas J Talley, Thanaboon Chaemsupaphan, et al.
Inflammatory Bowel Diseases|August 1, 2013
Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel diseaseChristian P Selinger, Jayne Eaden, D Brian Jones, et al.
European Journal of Gastroenterology & Hepatology|May 27, 2020
Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international surveyWebber Chan, Viraj C Kariyawasam, Shin Kim, et al.
Journal of Crohn'S & Colitis|May 13, 2014
Novel de novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel diseaseCheng Hiang Lee, Peter Hsu, Brigitte Nanan, et al.
Journal of Gastroenterology and Hepatology|October 3, 2018
Validation of the inflammatory bowel disease disability index for self-report and development of an item-reduced versionEmma Paulides, Catherine Kim, Chris Frampton, et al.
Neurogastroenterology and Motility|April 9, 2019
Achalasia diagnosed despite normal integrated relaxation pressure responds favorably to therapySantosh Sanagapalli, Sabine Roman, Audrey Hastier, et al.
Gut|March 21, 2023
Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feedingRobyn Laube, Christian P Selinger, Cynthia H Seow, et al.
Therapeutic Advances in Gastroenterology|February 13, 2026
Efficacy and safety of the interleukin-10-fragment F8 fusion protein PF-06687234 as add-on therapy to infliximab in patients with active ulcerative colitis: a randomized, phase IIa clinical trialStefan Schreiber, Silvio Danese, Séverine Vermeire, et al.
Therapeutic Advances in Gastroenterology|October 8, 2025
Adalimumab around the world: comparative analysis of products characteristics and patient support systemsTsz Hong Yiu, Emilia Anderson, Wai Keung Leung, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
The Lancet. Gastroenterology & Hepatology|December 5, 2021
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trialCraig Haifer, Sudarshan Paramsothy, Nadeem O Kaakoush, et al.
Therapeutic Advances in Gastroenterology|November 3, 2025
Microbiota-targeted strategies in IBD: therapeutic promise of 2'-fucosyllactose and beyondNicholas Fanous, Nicholas J Talley, Thanaboon Chaemsupaphan, et al.
Inflammatory Bowel Diseases|August 1, 2013
Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel diseaseChristian P Selinger, Jayne Eaden, D Brian Jones, et al.
European Journal of Gastroenterology & Hepatology|May 27, 2020
Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international surveyWebber Chan, Viraj C Kariyawasam, Shin Kim, et al.
Journal of Crohn'S & Colitis|May 13, 2014
Novel de novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel diseaseCheng Hiang Lee, Peter Hsu, Brigitte Nanan, et al.
Journal of Gastroenterology and Hepatology|October 3, 2018
Validation of the inflammatory bowel disease disability index for self-report and development of an item-reduced versionEmma Paulides, Catherine Kim, Chris Frampton, et al.
Neurogastroenterology and Motility|April 9, 2019
Achalasia diagnosed despite normal integrated relaxation pressure responds favorably to therapySantosh Sanagapalli, Sabine Roman, Audrey Hastier, et al.
Gut|March 21, 2023
Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feedingRobyn Laube, Christian P Selinger, Cynthia H Seow, et al.
Therapeutic Advances in Gastroenterology|February 13, 2026
Efficacy and safety of the interleukin-10-fragment F8 fusion protein PF-06687234 as add-on therapy to infliximab in patients with active ulcerative colitis: a randomized, phase IIa clinical trialStefan Schreiber, Silvio Danese, Séverine Vermeire, et al.
Therapeutic Advances in Gastroenterology|October 8, 2025
Adalimumab around the world: comparative analysis of products characteristics and patient support systemsTsz Hong Yiu, Emilia Anderson, Wai Keung Leung, et al.
Pageof 16